The preparation of new hydrogels by the reaction of α,β- polyasparthydrazide and glutaraldehyde is reported. A different crosslinking degree was obtained by varying the ratio crosslinking agent/polymer which influenced the swelling behavior of the gel. 5-Fluorouracil, was incorporated into the matrices during the crosslinking reaction and in vitro release studies were performed in simulated gastric juice (pH 1.1) and pH 7.4 buffer solution. The hydrogels prepared were chemically stable in the dissolution media. The observed data show the potential application of these new matrices for peroral administration of anticancer agents.
Get full access to this article
View all access options for this article.
References
1.
1. Giammona, G., B. Carlisi, A. Palazzo and S. Palazzo. 1989. Boll. Chim. Farm., 128:62.
2.
2. Giammona, G., B. Carlisi, G. Cavallaro, G. Pitarresi and S. Spampinato. 1994. J. Controlled Release, 29:63.
3.
3. Peppas, N. A.1988. Hydrogels in Medicine and Pharmacy. Vol. I Fundamentals. Boca Raton, FL: CRC Press, Inc.
4.
4. Lee, P. I. and C. J. Kim. 1991. J. Controlled Release, 16:229.
5.
5. Gutowska, A., Y. H. Bae, J. Feijen and S. W. Kim. 1992. J. Controlled Release, 22:95.
6.
6. Kudela, V.1987. Hydrogels, in: Encyclopedia of Polymer Science and EngineeringNew York: Wiley, 7:783-807.
7.
7. Heller, J., R. F. Helwing, R. W. Baker and M. E. Tuttle. 1983. Biomaterials, 4:262.
8.
8. Jeyanthi, R. and K. Panduranga Rao. 1990. J. Controlled Release, 13:91.
9.
9. Orienti, I., V. Bertasi and V. Zecchi. 1992. J. Controlled Release, 22:159.
10.
10. Gander, B., R. Gurny, E. Doelker and N. A. Peppas. 1989. Pharm. Res., 6(7):578.
11.
11. Korsmeyer, R. W. and N. A. Peppas. 1983. In Controlled Release Delivery Systems, Th. J. Roseman and S. Z. Mansdorf, editors, New York: Marcel Dekker.
12.
12. Korsmeyer, R. W. and N. A. Peppas. 1981. J. Membr. Sci., 9:211.
13.
13. Bae, Y. H., T. Okano, C. Ebert, S. Heiber, S. Dave and S. W. Kim. 1991. J. Controlled Release, 16:189.
14.
14. Peppas, N. A. and J. Klier. 1991. J. Controlled Release, 16:203.
15.
15. Schmahl, D. and M. R. Berger. 1988. Int. J. Exp Clin. Chemother, 1:1.
16.
16. Bos, E., P. Boon, F. Kaspersen and R. McCabe. 1991. J. Controlled Release, 16:101.
17.
17. Duncan, R., I. C. Hume, H. J. Vardley, P. A. Ilanagan, K. Ulbrich, V. Subr and J. Strohalm. 1991. J. Controlled Release, 16:121.
18.
18. Bosch, L., E. Harbers and C. Heidelberger. 1958. Cancer Rev., 18:335.
19.
19. Bounous, G., R. Pangeau and D. Regoli. 1978. Int. J. Chem. Pharmacol. Biopharm., 16:519.
20.
20. Chabner, B. A.1982. Pharmacologic Principles of Cancer Treatment, B. A. Chabner, ed., Philadelphia: Saunders, pp. 132-142.
21.
21. Boratynski, J. and T. Zal. 1990. Anal. Biochem., 184:259.
22.
22. Barberi-Heyob, M., J. L. Merlin and B. Weber. 1992. J. Chromatogr., 573(2):247.
23.
23. Gutowska, A., Y. H. Bae, J. Feijen and S. W. Kim. 1992. J. Controlled Release, 22:95.
24.
24. Song, S. Z., J. R. Cardinal, S. H. Kim and S. W. Kim. 1980. J. Pharm. Sci., 70(2):216.
